[A long-surviving patient with unresectable advanced gastric cancer treated with s-1 and biweekly Paclitaxel combination chemotherapy as second-line treatment].

Related Articles

[A long-surviving patient with unresectable advanced gastric cancer treated with s-1 and biweekly Paclitaxel combination chemotherapy as second-line treatment].

Gan To Kagaku Ryoho. 2012 Jul;39(7):1131-3

Authors: Oneyama M, Sekikawa K, Goto M, Kitamura M, Kawahara Y, Ohta R, Takahashi Y, Hirata Y, Nakayama M, Shimoda Y

Abstract
A 59-year-old man with type 3 gastric cancer(signet-ring cell carcinoma)underwent simple laparotomy because of peritoneal dissemination.S -1/CDDP was started.Since the icterus of Grade 2 had appeared after 2 courses, S-1 and biweekly paclitaxel combination chemotherapy was started as second-line treatment.Throughout treatment, there was no adverse event, and this regimen was continued for 14 courses(25 months).He died 32 months after his first visit.S -1/PTX may play an important role as second-line chemotherapy for patients with unresectable advanced gastric carcinoma.

PMID: 22790054 [PubMed - in process]

how to dissolve peptide peptide synthesis companies Natural products